Skip to content

Glutamate and the Neural Basis of the Subjective Effects of Ketamine

J.f.w. Deakin, Jane Lees, Shane Mckie, Jaime E. C. Hallak, S. R. Williams, Serdar Dursun

Archives of General Psychiatry February 1, 2008 DOI: 10.1001/archgenpsychiatry.2007.37 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Randomized controlled trial, crossover Placebo-controlled Double-blind Peer reviewed
Sample size 33
Population Healthy, right-handed men
Interventions Ketamine hydrochloride Lamotrigine
Dose 0.26 mg/kg bolus followed by 0.25 mg/kg/h maintenance infusion of ketamine; 300 mg of lamotrigine
Topics Ketamine Esketamine
Keywords Placebo Nmda receptor Glutamate receptor Anesthesia Crossover study Lamotrigine Dissociative Pharmacology Epilepsy
Citations 315
Key findings Ketamine induced a decrease in ventromedial frontal cortex activity that predicted dissociative effects and increased activity in posterior cingulate, thalamus, and temporal regions that correlated with psychosis scores, and lamotrigine pretreatment prevented many of these changes.

Abstract

CONTEXT: Ketamine evokes psychosislike symptoms, and its primary action is to impair N-methyl-D-aspartate glutamate receptor neurotransmission, but it also induces secondary increases in glutamate release.

Objectives: To identify the sites of action of ketamine in inducing symptoms and to determine the role of increased glutamate release using the glutamate release inhibitor lamotrigine.

Design: Two experiments with different participants were performed using a double-blind, placebo-controlled, randomized, crossover, counterbalanced-order design. In the first experiment, the effect of intravenous ketamine hydrochloride on regional blood oxygenation level-dependent (BOLD) signal and correlated symptoms was compared with intravenous saline placebo. In the second experiment, pretreatment with lamotrigine was compared with placebo to identify which effects of ketamine are mediated by increased glutamate release.

Setting: Wellcome Trust Clinical Research Facility, Manchester, England.

Participants: Thirty-three healthy, right-handed men were recruited by advertisements.

Interventions: In experiment 1, participants were given intravenous ketamine (1-minute bolus of 0.26 mg/kg, followed by a maintenance infusion of 0.25 mg/kg/h for the remainder of the session) or placebo (0.9% saline solution). In experiment 2, participants were pretreated with 300 mg of lamotrigine or placebo and then were given the same doses of ketamine as in experiment 1. MAIN OUTCOME MEASURES: Regional BOLD signal changes during ketamine or placebo infusion and Brief Psychiatric Rating Scale and Clinician-Administered Dissociative States Scale scores.

Results: Ketamine induced a rapid, focal, and unexpected decrease in ventromedial frontal cortex, including orbitofrontal cortex and subgenual cingulate, which strongly predicted its dissociative effects and increased activity in mid-posterior cingulate, thalamus, and temporal cortical regions (r = 0.90). Activations correlated with Brief Psychiatric Rating Scale psychosis scores. Lamotrigine pretreatment prevented many of the BOLD signal changes and the symptoms.

Conclusions: These 2 changes may underpin 2 fundamental processes of psychosis: abnormal perceptual experiences and impaired cognitive-emotional evaluation of their significance. The results are compatible with the theory that the neural and subjective effects of ketamine involve increased glutamate release.

Comparable studies

Other randomized controlled trials on ketamine, most cited first.

Study Year Design Participants
Subanesthetic Effects of the Noncompetitive NMDA Antagonist, Ketamine, in Humans Healthy human subjects recruited from the community 1994 Randomized controlled trial n = 19
Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial Patients with treatment-resistant major depression experiencing a major depressive episode 2013 Randomized controlled trial n = 73
Remifentanil-induced Postoperative Hyperalgesia and Its Prevention with Small-dose Ketamine Patients undergoing major abdominal surgery 2005 Randomized controlled trial n = 75
Efficacy of Intravenous Ketamine for Treatment of Chronic Posttraumatic Stress Disorder Patients with chronic PTSD related to a range of trauma exposures 2014 Randomized controlled trial n = 41
Ketamine-Induced Deficits in Auditory and Visual Context-Dependent Processing in Healthy Volunteers Healthy volunteers 2000 Single-blind placebo-controlled study n = 20

Citations in the library

Explore topics